Enliven Therapeutics Inc.

---

Enliven Therapeutics expenses grow as R&D ramps up

 November 13, 20231:56:39 pm

---

R&D spending drove increased Enliven Therapeutics loss in Q2

 August 14, 20232:37:42 pm

---

Enliven Therapeutics files $200M shelf registration

 June 27, 20237:18:42 am

---

Enliven’s loss grows as drug trials progress

 May 12, 20233:08:04 pm

---

Enliven Therapeutics closes merger, $165M raise

 February 24, 20232:42:50 pm

---

Enliven Therapeutics merger with Imara coincides with $165 million raise

Entrepreneurs / Small Business  October 17, 202212:10:12 pm